RIV CAP (CNPOF, $0.08) was a top loser over the last three months, falling -5 to $0.08 per share. A.I.dvisor analyzed 227 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending December 19, 2024, and found that of them () exhibited an Uptrend while of them () demonstrated a Downtrend.